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Introduction 
Cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) are among the most common 
chronic, lifestyle-related diseases worldwide, with the total number of deaths from these diseases 
combined increasing over the past decade (2007 – 2017) from 21.1% to 43.2% (Roth et al. 2018). 
Conventional risk factors for cardiometabolic diseases (CMD) include lifestyle behaviours, such as lack 
of physical activity, tobacco smoking, alcohol consumption and unhealthy dietary habits. While sleep 
has long been associated with mental health (Ford and Kamerow 1989), sleep duration has emerged 
recently as a factor contributing to CMD. 
More specifically, habitual short sleep duration (<7h) has been associated with increased risk for 
obesity, T2DM, hypertension, CVD, the metabolic syndrome and early mortality (Covassin and Singh 
2016; Fernandez-Mendoza et al. 2017; Gallicchio and Kalesan 2009; Sullivan and Ordiah 2018;
Tobaldini et al. 2019). While current recommendations are 7–9h sleep per night for optimal physical 
and mental health (Hirshkowitz et al. 2015; Watson et al. 2015), recent findings suggest that time 
allotted to sleep may have gradually declined over the past decades in the general population 
(Matricciani et al. 2017). 
Work and sleep have been identified as the main components of adult time use and longer working 
hours are associated with shorter sleep duration across all sociodemographic strata in employed 
adults (Basner et al. 2007). A growing proportion of the working population has been found to curtail 
sleep or experience sleep fragmentation in response to factors such as prolonged working hours and 
job stress (Basner et al. 2007; Control and Prevention 2012; Kuhn and Lozano 2005). This is particularly 
true among corporate executives who typically have complex work tasks, more cognitively demanding 
jobs, greater responsibilities and higher work demands, compared to blue collar workers (Åkerstedt 
et al. 2019). Insufficient sleep occurs when one’s sleep need is not met, consequently impacting 
daytime alertness, performance, and health. Resultant daytime tiredness or fatigue may impair work 
performance by decreasing high-order cognitive processes required for decision-making pertinent to 
leadership roles (Budnick and Barber 2015; Lim and Dinges 2010; Miller et al. 2014; Wild et al. 2018). 
Self-reported short sleep duration (≤6h per night) has been shown to vary by occupation, with the 
prevalence of short sleep duration being greatest for employees in managerial (40.5%), followed by 
those in transportation (37.1%) and manufacturing (34.8%) roles (Luckhaupt et al. 2010). Such 
literature gives insight into the sleep duration of occupational groups, and provides plausible 
correlates of shortened sleep in the broader population, but not in corporate executives for whom 
sleep appears to be jeopardised by longer work hours and high levels of stress (Ganesh et al. 2018; 
Nishitani et al. 2013). 
Both working hours and stress contribute to shorter sleep (Control and Prevention 2012; Kuhn and 
Lozano 2005; Nakashima et al. 2011), which in turn has been linked to poor cardiometabolic health 
outcomes. Cardiometabolic health is often studied in shift and blue collar workers, showing an 
association between poor sleep and the metabolic syndrome (Wang et al. 2014), diabetes (Gan et al. 
2014) and obesity (Sweeney et al. 2018), while less is known about the sleep of employees in 
administrative, professional and managerial positions. In these corporate executives, the focus of the 
research appears to be directed more towards the work-related and psychosocial impact on sleep. For 
example, in one study, high job strain has been significantly associated with burnout, but only in the 
employees experiencing sleeping difficulties defined as insomnia or non-restorative sleep disorders 
(Metlaine et al. 2017); while in another study, shorter sleeping time was associated with depressive 
symptoms and anxiety (Nishitani et al. 2018). 
Although companies have utilized corporate health risk assessments (HRAs) to measure the health of 
their executive employee population for more than a decade, sleep is often overlooked, especially in 
a unique cohort of managerial employees for whom extended work hours, high job stress and sleep 
deprivation may contribute to suboptimal long-term health. The observed associations between 
stress (Choi et al. 2018), long working hours (Reynolds et al. 2018) and physical inactivity (Vincent et 
al. 2017) with short sleep duration and consequent impact on cardiometabolic health in employed 
adults raise the possibility that these factors potentially play an intermediary role in the pathway from 
sleep duration to cardiometabolic disease risk factors. Identifying whether working, stress and/or 
physical activity levels mediate this relationship may provide insight into how variables are associated. 
To the best of our knowledge, this has not been tested in corporate executives. 
The first aim was to describe occupational and psychological correlates of self-reported sleep duration 
in corporate executives, defined as those in senior management or executive positions. The second 
aim was to explore associations between self-reported sleep duration and cardiometabolic risk factors 
in these employees. Given the limited research on sex differences with respect to cardiometabolic 
risk and sleep (Meers et al. 2019; Silva-Costa et al. 2020), particularly in occupational health studies, 
we attempted to address this gap and stratified our analyses by sex. Further, since it may mediate 
the magnitude thereof, the third aim was to explore the extent to which physical activity, work- or 
stress-related factors might mediate the association between sleep duration and cardiometabolic risk 
factors. 
Methods 
Design, setting and participants 
This cross-sectional study used corporate health programme data from 3585 managerial employees 
at 56 companies in South Africa, who underwent health assessments between 2016 and 2019. The 
companies were from different industrial sectors which included information technology, finance, 
telecommunication services, health, construction and engineering, consulting, manufacturing and 
production, retail and wholesale trade, mining, transportation, hospitality. 
Participants included in this study were male and female full time employees in senior or executive 
management positions. Their health assessments comprised a web-based health risk assessment 
(HRA), followed by a face-to-face comprehensive clinical consultation. Participants were excluded 
from this study if they were shift workers (n=0), did not have self-reported sleep duration data 
(n=317), or if there were missing data for sex (n=2). The study was approved by the Human Research 
Ethics Committee at the University of Cape Town (HREC ref. no: 470/2017) and informed consent was 
obtained from all participants. 
Data collection instruments and measures 
Health risk assessment (HRA) questionnaire 
The HRA included questions on participant demographics (sex, age), sleep, medical history, 
occupational, psychological well-being and modifiable lifestyle factors. Sleep duration (h/night) was 
recorded in response to the question “How many hours, on average, and not including naps, do you 
usually sleep during the night?”. Response options ranged from <5h to ≥10h in increments of 30 
minutes. Self-reported sleep duration was analysed as a continuous variable throughout this study. 
Sleep quality was measured with the question “In general, how would you rate your sleep?” with 
response choices: (1) very good, (2) good, (3) average, (4) poor, and (5) very poor. Fatigue interfering 
with daytime function was measured with the question ‘How often have you experienced sleepiness 
or fatigue that interfered with your daily activities (work and/or social)?” and the response scale was: 
(1) rarely or never, (2) a few days a month, (3) a few days a week, (4) every or almost every day. This 
question was introduced in 2018, and consequently there are some missing data for this question. 
The occupational variables included hours worked per week; travel time to and from work (min/day); 
absenteeism and presenteeism. Hours worked per week was stratified into three categories: (1) 
<40h/week, (2) 40-60h/week, and (3) >60h/week. Absenteeism, defined as absence from work owing 
to sickness, was measured by a single question “How many days were you absent from work during 
the last year as a result of illness?”. Responses were: (1) 0 days/year, (2) 1-6 days/year, (3) 7-14 
days/year, (4) 15 days/year or more. Presenteeism was measured by the following question: “Over 
the past 12 months, how often have you gone to work despite feeling that you really should have 
taken sick leave because of your state of health?” Response options were: (1) never, (2) 1-2 
times/year, (3) 3-4 times/year, (4) 5 times/year or more. Since presenteeism was only incorporated 
into the HRA in 2018, there are some missing data for this variable. 
Psychological well-being was assessed using the Depression, Anxiety and Stress Scale (DASS)-21, which 
consists of 21 statements measuring three subscales: depression, anxiety and stress, as felt over the 
past week (Lovibond and Lovibond 1995b). Each subscale consists of seven items measured on a four-
point scale ranging from 0 = Did not apply to me at all, to 3 = Applied to me very much, or most of the 
time. The DASS-21, which is a shortened version of the DASS-42, has been validated in non-clinical 
samples (Dreyer et al. 2019; Henry and Crawford 2005), and psychometric properties of this 
instrument have previously been reported to have Cronbach’s alpha scores of α = 0.92 (Mean: 717;
standard deviation (SD): 5.39) for stress; α = 0.90 (Mean: 4.06; SD: 4.51) for anxiety; and α = 0.86 
(Mean: 4.85; SD: 4.84) for depression (Lovibond and Lovibond 1995a). The outcome variables were 
treated as categorical variables for depression, anxiety and stress symptoms. The sum scores were 
computed by adding up the scores on the items per subscale and multiplying them by a factor of 2 in 
order to yield equivalent scores to the full DASS-42. Sum scores for each subscale ranged between 0 
and 42 with severity ratings as shown in Supplementary Table 1. These cut-off scores were derived 
from a set of severity ratings, proposed by Lovibond and Lovibond (Lovibond and Lovibond 1996). 
The lifestyle variables included physical activity (PA, min/week), smoking status and alcohol 
consumption. Participants reported the number of physical activity (PA) sessions they took part in 
during a typical week and the duration of each session, from which the average minutes of PA per 
week were calculated. PA time per week was analysed as a continuous variable for descriptive 
statistics and incorporated as a dichotomous mediator for mediation analyses (<150 or ≥150min/week 
PA). Smoking status and alcohol consumption were analysed as categorical outcome variables. 
Smoking status was recorded as “current smoker”, “ex-smoker” or “never smoker”, but for the 
purpose of this study, smoking was analysed as a dichotomous variable (current smoker vs current 
non-smoker). Employees provided information on alcohol consumption by choosing from the 
following: (1) never consume alcohol, (2) less than 14 alcoholic drinks/week, (3) 14-21 drinks/week, 
and (4) more than 21 drinks/week. 
Clinical assessment 
Cardiometabolic risk factors 
Standing height (cm) was measured to the nearest cm, using a stadiometer and body weight was 
measured using a portable calibrated scale and recorded to the nearest 0.1kg. Body mass index (BMI) 
was calculated as weight (kg) divided by height (m) squared (kg/m2). Waist circumference (WC) was 
measured around the midpoint of the lowest rib and iliac crest, to the nearest 0.1cm. Resting systolic 
blood pressure (SBP, mmHg) and diastolic blood pressure (DBP, mmHg) were measured by the 
consulting medical doctor using a mercury sphygmomanometer and cuff size appropriate to the 
participant’s arm circumference. Following a 10h overnight fast, venous blood samples were drawn 
and sent to a clinical pathology laboratory (Pathcare, Lancet or Ampath Laboratories) to measure 
fasting plasma glucose (Glu, mmol/L), high density lipoprotein-cholesterol (HDL, mmol/L) and 
triglyceride (TG, mmol/L) concentrations. 
Cardiometabolic risk score 
A continuous cardiometabolic risk score was calculated by summing the standardized scores for 
negative fasting serum HDL, and positive plasma Glu, serum TG, BMI, WC, SBP and DBP. This clustered 
cardiometabolic risk score was calculated for each participant as follows: 
Cardiometabolic risk score = -zHDL + zGlu + zTG + [(zBMI + zWC)/2] + [(zSBP + zDBP)/2] 
We used this score to estimate an individual’s overall cardiometabolic risk. In contrast to using 
dichotomous metabolic syndrome characteristics, this approach provides a continuous risk score 
which increases statistical power, and has been used in previous studies (Chaput et al. 2013; 
Kanagasabai and Chaput 2017). A higher score indicates a less favourable metabolic profile. 
Data and statistical analyses 
Data are presented as mean ± standard deviation (SD), median with the interquartile range (IQR), or 
count (%). Descriptive comparisons between the men and women were conducted using Mann 
Whitney U, Chi-Squared or Fisher’s Exact tests. Linear regressions were performed to explore 
occupational and psychological correlates of self-reported sleep duration and to analyse associations 
between self-reported sleep duration and cardiometabolic risks. For the purpose of this study, the 
Extremely Severe category of the DASS-21 questionnaire was collapsed into the Severe category. All 
models were adjusted for age, alcohol consumption, smoking and physical activity. 
We used mediation analyses for all significant associations between sleep duration and 
cardiometabolic characteristics, to explore mediating effects of work hours, stress and physical 
activity (Baron and Kenny 1986). Figure 2 shows the path diagrams where the product of the a and b 
coefficients defines the indirect effect of X (independent variable) on Y (dependent variable) through 
M (mediator). We used 1000 bootstrapping samples to generate 95% confidence intervals (CI) for the 
different effects being examined. In this study, X refers to self-reported sleep duration, Y refers to 
cardiometabolic risk and M refers to the mediators: work hours, stress or physical activity. We 
adjusted for age, smoking, alcohol consumption and physical activity in all models, except for where 
physical activity was the mediator. Our outcomes are presented (Figure 2) by displaying the indirect 
(effect of M through paths a and b), direct (effect of sleep duration on the outcome variable, 
controlling for M, path C’) and total effects (effect of sleep duration on the outcome variable, path C). 
Data were analyzed using Stata (v.15, StataCorp, Texas, USA) and significance accepted using an alpha 
value of p<0.05.  
Results 
Participant characteristics 
Descriptive characteristics of the sample are presented in Table 1. Whereas the sleep duration median 
was 7h for both men and women, 20.6% of men and 26.5% of women reported a sleep duration <7h. 
Sleep duration within the 7-9h range was reported in 79.5% of the men and 73.5% of the women. No 
participants reported a sleep duration >9h. 
Significant differences were observed between men and women for all factors except sleep duration, 
sleep quality and smoking status. Compared to women, men were older (p<0.01), reported less fatigue 
interfering with their daytime function (p=0.020), longer working hours (p<0.001), more commuting 
time to work (in the 21-60min category, p=0.006), less absenteeism (p<0.001), less frequent 
presenteeism (p=0.004), less depression (p<0.001), anxiety (p<0.001) and stress (p<0.001), were more 
physically active (p<0.001) and consumed more alcohol per week (p<0.001). 
Cardiometabolic risk factors of the men and women are presented in Table 2. In general, 29.3% and 
24.1% of the men and women were obese; 45% of men and 17.9% of women had hypertension or 
elevated blood pressure; and elevated blood glucose or diabetes was prevalent in 23% of the men and 
7.8% of the women in this cohort. Men had a larger WC (p<0.001), higher BMI (p<0.001), Glu 
(p<0.001), TG (p<0.001), SBP and DBP (both p<0.001) and lower HDL (p<0.001) concentrations 
compared to women. Similarly, a greater proportion of the men were obese (p=0.002) and they had 
a higher cardiometabolic risk score than women (p<0.001). 
Occupational and psychological correlates of self-reported sleep duration 
The occupational and psychological correlates of self-reported sleep duration are presented in Table 
3. In the fully adjusted models, men who reported longer work hours (>60 vs 40-60 h/week; p<0.001) 
and a longer travel time to work (>60 vs <20min/day; p=0.012) had shorter sleep durations. Similarly, 
in women, working more than 60h/week (vs 40-60h/week, p=0.001), and travelling 21-60min/day 
(p=0.041) or >60min/day (p=0.009) vs <20min/day to and from work were associated with shorter 
sleep durations. Among the men, mild (p=0.002) and moderate (p=0.002) depression scores, 
moderate (p<0.001) and severe (p<0.001) anxiety scores and mild (p=0.001), moderate (p<0.001) and 
severe (p<0.001) stress scores were associated with shorter sleep durations compared to those with 
normal symptom levels. Among the women, mild depression (p<0.01), severe anxiety (p=0.008) and 
mild (p=0.022), moderate (p=0.028) and severe (p=0.002) stress scores were associated with shorter 
sleep duration. 
Associations between self-reported sleep duration and cardiometabolic risk factors 
Table 4 presents unadjusted and adjusted models of the associations between self-reported sleep 
duration and cardiometabolic risk factors. In the fully adjusted models, higher BMI (p=0.002), larger 
WC (p=0.001), higher DBP (p=0.027) and a greater cardiometabolic risk score (p<0.001) were 
associated with shorter self-reported sleep duration in men. Among the women, higher BMI 
(p=0.040), larger WC (p=0.028), lower HDL (p=0.027) and a greater cardiometabolic risk score 
(p=0.036) were associated with shorter self-reported sleep durations. The association between self-
reported sleep duration and cardiometabolic risk score is shown in Figure 1. 
Mediation analyses 
Table 5 shows the results of the mediation analyses for men, in whom working hours, stress symptoms 
and physical activity mediated the main associations between sleep duration and BMI, WC, DBP and 
cardiometabolic risk score. The magnitudes were small but significant for the indirect effects of self-
reported sleep duration and (1) BMI through working hours (p=0.015); stress (p=0.033) and physical 
activity (p=0.006). Similarly, the magnitudes of the indirect effects were significant for the relationship 
between sleep duration and (2) WC, through working hours (p=0.005), stress (p=0.044) and physical 
activity (p=0.004); (3) DBP through working hours (p=0.026), stress (p=0.044) and physical activity 
(p=0.009) and (4) cardiometabolic risk score through working hours (p=0.019), stress (p=0.024) and 
physical activity (p=0.004). No mediation effects were observed for women (Supplementary Table S2) 
Discussion 
Working hours, work-related commute time and stress were found to be the occupational and 
psychological factors associated with shorter sleep duration in this cohort of corporate executives. 
Our findings further suggest that compared to their longer sleeping colleagues, the men with shorter 
sleep durations were more likely to have higher BMI, WC, DBP and overall cardiometabolic risk scores, 
while shorter sleeping women were more likely to have higher BMI, WC and cardiometabolic risk 
scores, but lower HDL. Working hours, stress and physical activity appear to mediate these 
relationships among the male but not the female corporate executives. 
Female corporate executives had a lower mean cardiometabolic risk score, compared to their male 
counterparts (Kanagasabai and Chaput 2017), and when comparing the associations between sleep 
and individual cardiometabolic risk factors, it is evident that men and women presented with distinctly 
different outcomes which may be explained by variances in body composition (adiposity) and 
hormonal regulation (Pradhan 2014). Specifically, sex differences were observed in the relationships 
between sleep duration, DBP and HDL cholesterol. Only among the male executives was sleep 
duration inversely associated with DBP, which is in contrast to previous literature reporting that sleep-
deprived women were at a greater risk of developing hypertension (Dean et al. 2012). However, the 
average age of women in studies investigating sleep and hypertension was approximately 55 years 
(Cappuccio et al. 2007; Di Giosia et al. 2018), which may correspond to the decrease in oestrogen 
occurring during menopause. Moreover, the same studies showed that the greatest risk for high blood 
pressure were in women sleeping <5h (Cappuccio et al. 2007; Di Giosia et al. 2018). In our sample of 
1042 women, only 262 reported <6h sleep per day and their mean age was 43 years. Therefore, we 
could speculate that our contrasting finding may partly be due to the younger age of our participants, 
and the smaller proportion reporting on short sleep duration. 
In women, longer sleep duration was associated with higher HDL cholesterol concentration and is in 
line with findings reported by Kaneita et al., that sleep duration of ≤6h/day was linked to low serum 
HDL cholesterol in women specifically (Kaneita et al. 2008). While the mechanisms behind these sex-
specific associations are unclear, the most consistent findings seem to be that short sleep is associated 
with adverse effects on lipid metabolism, including lower HDL cholesterol levels (Aho et al. 2016). 
Mediators of the association between sleep duration and cardiometabolic risk was only observed in 
men. More specifically, longer work hours, physical activity and higher stress scores were found to 
mediate the associations between sleep duration and BMI, WC, DBP and cardiometabolic risk score. 
Since this mediating effect was small, it is plausible that had we had a greater sample of women in our 
study, similar findings may have been observed. Alternatively, we speculate that other factors that 
were not measured in this study, such as family responsibilities or childcare, may have been more 
suitable mediators in women. For example, research conducted by Nemoto et al. 2012 exploring the 
association between long work hours and the gender divide in corporate Japan showed that women 
managers were still being expected to fulfil a ‘dual-role’ of being a care-taker and ideal worker 
(Nemoto 2013). Similarly, Cho et al. 2015 described a ‘double burden’ of work and family 
responsibilities in white collar women employees (Cho et al. 2015). Additionally, the men in this study 
reported significantly longer work hours and higher physical activity levels relative to the women 
which may have further strengthened the mediating effect. 
In a study corroborating the interrelationship between sleep, work, physical activity and BMI, Magee 
et al. (2011) found a link between working hours, sleep duration and obesity, such that short sleep 
partially mediated the association between long work hours and increased BMI. Their study made no 
differentiation between shift or non-shift workers, and their BMI was self-reported. Since shift work 
is associated with many adverse health outcomes including obesity, CVD and CMD (Kervezee et al. 
2020), and self-reporting weight and height could be prone to reporting biases, our study that 
excluded shift workers and utilized objective anthropometric measurements, would potentially have 
reduced such bias. 
The odds of higher perceived stress in short sleepers (≤7h/day) have been reported in employees with 
specialized work and in office workers, when compared to those in manual labour (Choi et al. 2018); 
and in another study, the primary predictor of short sleep in obese employees was stress (Vgontzas 
et al. 2008). Insufficient sleep may evoke a stress response, contributing to fat deposition and raised 
blood pressure, both of which are features of the shorter sleeping men in this cohort. 
While poor sleep may reduce motivation to be physically active (Patel and Hu 2008) and increase 
daytime sleepiness, lower levels of physical activity have also been associated with increased daytime 
fatigue (McClain et al. 2014), which over time, could promote weight gain and obesity via reduced 
energy expenditure. Taken together, a concomitant decrease in sleep duration and increase in stress 
may thus play an important role in linking stress with cardiometabolic risk, while lower physical activity 
levels may partly explain the relationship between sleep and obesity. 
Our findings suggest that extended work hours increase the likelihood for obesity, and corroborate 
the work of Di Milia and Mummery, who found that long daily working hours (12h/day), and short 
sleep (≤7h/day), were predictors of obesity (Di Milia and Mummery 2009). Moreover, older executives 
who worked ≥50h/week and slept ≤47h/week in their midlife reported poorer physical health and 
function (i.e. health-related quality of life) in old age (von Bonsdorff et al. 2017). Since our overall 
cohort had a mean age of 45 years of which many reported sleeping <7h and working ≥60h/week, our 
results are important in implementing a pro-active approach to workplace health, mitigating future 
adverse cardiometabolic risks, and promoting a better health-related quality of life. The combined 
effect of long work hours and short sleep duration may therefore amplify the risk for cardiometabolic 
diseases, such as CVD and T2DM. 
Strengths of this study include the well-characterized sample of corporate executives who came from 
a similar working background and who participated in a standardized routine data collection 
procedure, which included a HRA and face-to-face clinical assessments. Seldom are men and women 
described separately in employee cohorts, and to our knowledge this is the first to do so regarding 
sleep duration and cardiometabolic risk in corporate executives. 
Self-reported data that were used to describe the sleep and work-related characteristics (e.g. 
absenteeism, presenteeism, travel time) of the cohort may have suffered from recall biases, which is 
a limitation to this study. Future work would therefore benefit by incorporating objective measures 
of sleep such as actigraphy or polysomnography. However, the data obtained were from standardised 
HRAs, which were most convenient for a cohort of corporate executives with time constraints and 
high job demands. Secondly, as this was a cross-sectional study in a unique subset of the working 
population, causal relationships could not be determined and the findings cannot be generalized. 
However, it provides some insight into correlates of short sleep duration, and the relationship of sleep 
with cardiometabolic risk factors in an exclusive sample of business executives and managers, and 
future studies may extend into different levels of employment allowing for a greater understanding 
of these relationships in working adults. Thirdly, we only accounted for blood pressure, diabetes and 
cholesterol treatment to analyse cardiometabolic risk, and therefore there is potential for 
confounding by medications that affect sleep, mental health or that may interact to affect blood 
pressure or lipid profiles. 
Conclusion 
These findings provide insight into the relationship between sleep duration and cardiometabolic risk 
in corporate executives, and help to fill the gap in the literature by describing sex differences in this 
unique cohort. Long work hours, daily work commute time, elevated stress, anxiety and depression 
scores were apparent correlates of shorter sleep duration, which in turn was associated with 
cardiometabolic risk. These data suggest that corporate executives exhibiting elevated stress, anxiety 
and depression symptoms, those who work long hours, and have a long daily commute time to work 
may be vulnerable to poor cardiometabolic health outcomes by compromising sleep duration. This 
knowledge is useful since managers, executives and entrepreneurs are continually faced with long 
working hours, coupled with high pressures experienced in their job responsibilities. The potential to 
modify sleep and lower long term risk for CMD through interventions may differ depending on the 
correlates of sleep duration, and the mediators of this relationship with CMD. Our findings may thus 
assist companies to underpin underlying occupational and psychological factors such as working hours 
and stress, and provide a starting point for targeted sleep interventions to inform the workforce and 
its management about the potential health consequences of poor sleep. Such findings may provide 
additional evidence in this unique cohort, emphasizing workplace health programmes that promote a 
balance between work hours and sleep, combined with stress management in order to mitigate the 
development of CMD and its comorbidities in corporate executives. 
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